These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 627804)

  • 1. Adult nephrotic syndrome: Clinicopathological correlation and results of treatment.
    Indraprasit S; Boonpucknavig V
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():46-9. PubMed ID: 627804
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term follow up of steroid and cyclophosphamide therapy in nephrosis.
    Ghose S; Kumar M; Kundu B; Bindal S
    Indian Pediatr; 1977 Nov; 14(11):885-9. PubMed ID: 614301
    [No Abstract]   [Full Text] [Related]  

  • 4. The nephrotic syndrome in adults with 'minimal change' glomerular lesions.
    Cameron JS; Turner DR; Ogg CS; Sharpstone P; Brown CB
    Q J Med; 1974 Jul; 43(171):461-88. PubMed ID: 4422336
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide in the treatment of adult nephrotic syndrome.
    Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
    J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT; Yang LY
    J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
    Maezawa A; Hiromura K; Mitsuhashi H; Tsukada Y; Kanai H; Yano S; Naruse T
    Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nephrotic syndrome (a follow up study of 32 cases).
    Joshi MK; Kandoth PW; Sant SM; Bhagat MP
    J Postgrad Med; 1976 Jan; 22(1):26-31. PubMed ID: 966184
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

  • 15. Selectivity index as a therapeutic guide in nephrotic syndrome.
    Prasad R; Dayal RS; Mittal VP; Srivastava VK; Bedi GK; Bhatnagar AK
    Indian Pediatr; 1975 Mar; 12(3):211-5. PubMed ID: 1158483
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cyclophosphamide therapy of nephrotic syndrome in childhood].
    Krepler P; Rosenkranz A; Obiditsch-Mayer I; Stockinger L; Schatz H; Fritzsche H
    Arch Kinderheilkd; 1970; 181(3):268-82. PubMed ID: 4922851
    [No Abstract]   [Full Text] [Related]  

  • 18. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary nephrotic syndromes in children in Iran].
    Bodaghi E; Chamsa AM
    Ann Pediatr (Paris); 1978 Jan; 25(1):61-70. PubMed ID: 16114307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.